Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Platelet-Rich Plasma for Wound Treatment in Venous Leg Ulcers

Focus of the Report: This report focuses on the efficacy and safety of platelet-rich plasma (PRP) for treatment of venous leg ulcers (VLUs).

Technology Description: PRP is an autologous blood preparation with a higher-than-usual concentration of platelets, platelet-derived growth factors, and other cytokines. Protocols for PRP preparation vary consider…

Somryst (Pear Therapeutics Inc.) for Treatment of Insomnia

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Somryst (Pear Therapeutics Inc.) for the treatment of chronic insomnia in adults.

Rezūm System (Boston Scientific Corp.) for Benign Prostatic Hyperplasia

Focus of the Report: This report focuses on Rezūm water vapor therapy for the treatment of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).

Technology Description: Rezūm is a minimally invasive surgical therapy that utilizes the convective principles …